RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer.

Desiree' DeandreisAline MaillardSlimane ZerdoudClaire BournaudLavinia VijaChristophe SajousMarie TerroirLaurence LeenhardtMartin SchlumbergerIsabelle BorgetSophie Leboulleux

Published in: European journal of nuclear medicine and molecular imaging (2021)

NCT02390934. Registration date 18.03.2015.

Keyphrases

open label
cross sectional
randomized controlled trial
magnetic resonance imaging
computed tomography